First human tests for new HIV pill begin
NCT ID NCT07042945
Summary
This is an early safety study for a new oral HIV medication called MK-4646. It will test the drug in a small group of people with HIV who have not yet started standard treatment. The main goals are to see if the pill is safe and if it can lower the amount of HIV virus in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ARENSIA Exploratory Medicine ( Site 0001)
RECRUITINGBucharest, București, 021105, Romania
Contact Phone: •••-•••-••••
-
PMSI Republican Clinical Hospital "T.Mosneaga" ( Site 0002)
RECRUITINGChisinau, 2025, Moldova
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.